Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Continuous advancements in diagnostic imaging technologies assume a vital part in shaping market trends. High-resolution magnetic resonance imaging (MRI) and computed tomography (CT) scans empower exact and early detection of syringomyelia, working with brief intercession. The emphasis on early diagnosis drives the market for these high-level imaging modalities.
Surgical interventions stay an essential focus in the treatment of syringomyelia. The market reflects a pattern towards various surgical techniques, including decompression surgeries, shunt placements, and minimally invasive procedures. These interventions expect to address the hidden causes and oversee cerebrospinal liquid dynamics to forestall or ease syrinx formation.
There is a striking pattern towards minimally invasive surgical techniques in the syringomyelia market. Surgeons are increasingly exploring procedures that limit tissue disruption, lessen postoperative complications, and speed up recuperation. Minimally invasive approaches line up with the more extensive pattern in neurosurgery to improve patient outcomes and personal satisfaction.
As there is at present no remedy for syringomyelia, there is a developing focus on symptom management and working on patients' personal satisfaction. Palliative consideration, physical treatment, and multidisciplinary approaches that address both the physical and psychological aspects of the condition are becoming basic components of the treatment landscape.
The coordination of telemedicine in nervous system science is impacting the syringomyelia market, permitting patients to access distant consultations with specialists. This is especially advantageous for individuals with restricted access to specialized medical care facilities or those confronting versatility challenges. Telemedicine contributes to worked on persistent commitment and progressing care.
While the market as of now lacking specific disease-adjusting therapies, the market is witnessing efforts to explore potential treatment options that can alter the course of syringomyelia. Research into pharmacological interventions, regenerative medication, and neuroprotective agents aims to distinguish novel strategies to slow disease progression.
Syringomyelia Market Highlights:
Syringomyelia Market Overview
Syringomyelia Market Size was valued at USD 0.2 Billion in 2023. The Global Syringomyelia industry is projected to grow from USD 0.3 Billion in 2024 to USD 0.5 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.20% during the forecast period (2024 - 2032).
Syringomyelia is a chronic condition characterized by a fluid-filled cyst known as a syrinx that forms within the spinal cord. The syrinx can expand over time, and destroy the surrounding nerve tissue. There are several possible causes of syringomyelia but most cases are associated with Chiari malformation. Symptoms of syringomyelia may include pain, stiffness in the back, shoulders, neck, arms, or legs, progressive weakness in the arms and legs, headaches, imbalance, loss of bowel and bladder control, the curvature of the spine (scoliosis), numbness, or tingling.
There are majorly two forms of syringomyelia: congenital syringomyelia and acquired syringomyelia. The congenital syringomyelia is caused by a Chiari malformation, whereas causes of acquired syringomyelia include meningitis, spinal cord injury, a spinal cord tumor, arachnoiditis, tethered cord syndrome, and bleeding into the cord (hemorrhage).
According to the National Organization for rare diseases, syringomyelia is most commonly found in young adults between the ages of 20-40 years, but can also develop in young children or older adults. It is also reported that the condition is slightly more common in males than females.
Notably, rising need for the better treatment methods is the key factor driving the syringomyelia market growth. A number of scientist and researcher are continuously trying to find ways to halt or reverse the cell damage occurred due to spinal cord injury. Diagnostic technology is another area of continued research to better visualize conditions in the spine even before symptoms appear.
Various other factors such as increasing prevalence of syringomyelia, and related complications, increasing government assistance, improving regulatory framework, increasing awareness, and rising funding and reimbursement are continuously contributing to the growth of the syringomyelia market.
However, high treatment cost, injuries occurred because of treatment, and poor healthcare system in low and middle-income countries may hinder the growth of the market to an extent over the review period.
Syringomyelia Market Key Players
Some of key the players in the syringomyelia market are:
- Stryker
- Medtronic Plc
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Johnson & Johnson Private Limited
- CONMED Corporation
- Novartis AG
- Smith & Nephew PLC
- Zimmer Holdings Inc.
- TransEnterix, Inc.
- Becton
- Dickinson and Company
- Aspen Surgical Products, Inc.
- Olympus Corp.
- Richard Wolf GmbH
- Siemens Ltd.
- STORZ MEDICAL AG
Intended Audience
- Pharmaceutical Companies
- Research and Development (R&D) Companies
- Diagnostic Laboratories
- Government Research Institute
- Academic Institutes and Universities
Syringomyelia Market Segmentation
The syringomyelia market is segmented on the basis of type, diagnosis, treatment, and end user.
On the basis of the type
The syringomyelia market is classified as congenital syringomyelia (communicating syringomyelia) and acquired syringomyelia (noncommunicating syringomyelia).
On the basis of the diagnosis
The syringomyelia market is classified as magnetic resonance imaging (MRI), computerized tomography (CT) scan, and others.
On the basis of the treatment
The syringomyelia market is classified as monitoring, surgical care, and medication. The surgical care is further segmented into Chiari surgery, expansive duraplasty, surgical removal of the obstruction, draining the syrinx (shunt operation), and others. The medication is further segmented into analgesics, muscle relaxants, and others.
On the basis of the end user
The syringomyelia market is segmented into hospitals, clinics, diagnostic centers, drug stores, pharmacies, and others.
Research Methodology 
Sources: Annual reports, Press release, White paper, and Company presentation
Syringomyelia Market Regional Analysis
The Americas dominate the syringomyelia market owing to the rising awareness among people and high healthcare expenditure. According to the Centers for Disease Control and Prevention in 2015, the total health expenditure in the United States was reported to be USD 3.2 trillion and hospital care accounted for a share of 32.3%.
Europe holds the second position in the syringomyelia market. It is expected that the support provided by the government bodies for research & development and improvement in reimbursement policies in the healthcare is likely to drive the market of Europe region.
The Asia Pacific is the fastest growing syringomyelia market owing to a huge patient pool and developing healthcare technology. Healthcare expenditure is also improving in various Asia Pacific countries. According to the Australian Institute of Health and Welfare in the years 2015-2016, the total health expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure of 2014-2015.
The Middle East & Africa holds the least share of the market due to lack of technical knowledge and poor medical facilities.
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
